Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients

Pediatrics

Volumn 123, Issue 5, 2009, Pages 1360-1368

  Blyth, Christopher C ^a   Chen, Sharon C A ^a,b   Slavin, Monica A ^c   Serena, Carol ^a   Nguyen, Quoc ^d   Marriott, Deborah ^d   Ellis, David ^e   Meyer, Wieland ^a,b   Sorrell, Tania C ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Adult; Antifungal agents; Candida; Candidiasis; Child; Fungemia; Infant; Newborn

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; POSACONAZOLE; PYRROLE; VORICONAZOLE;

ADOLESCENT; ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; AUSTRALIA; BACTERIUM ISOLATE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NEUTROPENIA; NEWBORN; OUTCOME ASSESSMENT; PEDIATRICIAN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; VASCULAR ACCESS;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; AUSTRALIA; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DNA FINGERPRINTING; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEOPLASMS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 66149142200     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2055     Document Type: Article

References (42)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29(2):239-244 (Pubitemid 29380177)
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-1554 (Pubitemid 36437931)
3. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17(6):504-508 (Pubitemid 28287618)
4. Manno G, Scaramuccia A, Rossi R, Coppini A, Cruciani M. Trends in antifungal use and species distribution among Candida isolates in a large paediatric hospital. Int J Antimicrob Agents. 2004;24(6):627-628 (Pubitemid 39536125)
5. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis. 2002;35(5):627-630
6. Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996;100(6):617-623 (Pubitemid 26243671)
7. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41(9):1232-1239 (Pubitemid 41532664)
8. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J. 1996;15(12):1107-1112 (Pubitemid 27014703)
9. Mondal RK, Singhi SC, Chakrabarti A, M J. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. Pediatr Crit Care Med. 2004;5(6):561-565
10. Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008;27(9):820-826
11. Chen S, Slavin M, Nguyen Q, et al. Active surveillance for candidemia, Australia. Emerg Infect Dis. 2006;12(10):1508-1516 (Pubitemid 44570891)
12. Australian Government Department of Health and Aging. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting 2004. Available at: www.health.gov.au/internet/main/ publishing.nsf/content/icg-guidelines-index.htm. Accessed April 12, 2008
13. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-638
14. Warren NG, Hazen KC. Candida, Cryptococcus and other yeasts of medical importance. In: Murray RP, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology. Washington, DC: American Society of Microbiology Press; 1999:1184-1199
15. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast: approved standard. In: CLSI M27A-2 Protocol. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002
16. Meyer W, Latouche GN, Daniel HM, et al. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis. 1997;18(9):1548-1559 (Pubitemid 27395760)
17. Meyer W, Maszewska K, Sorrell TC. PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol. 2001;39(2):185-193 (Pubitemid 32377316)
18. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43(1):284-292 (Pubitemid 40096313)
19. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories. Canberra, Australia: The Bureau; 2004
20. Australian Institute of Health and Welfare. Australian Hospital Statistics 2003-2004. AIHW catalog No. HSE 37. Canberra, Australia: Australian Institute of Health and Welfare (Health-Services Series No. 23); 2005. Available at: www.aihw.gov.au. Accessed April 12, 2008
21. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis. 1999;29(5):1164-1170 (Pubitemid 30265634)
22. Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis. 2003;9(8):985-990
23. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42(4):1519-1527 (Pubitemid 38500790)
24. Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43(4):1829-1835 (Pubitemid 40491227)
25. Asmundsdóttir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol. 2002;40(9):3489-3492
26. Cotten CM, McDonald S, Stoll B, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118(2):717-722 (Pubitemid 46085430)
27. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345(23):1660-1666 (Pubitemid 33126821)
28. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med. 1989;149(10):2349-2353 (Pubitemid 19258182)
29. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study: the National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177-186
30. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr. 2005;147(2):156-161 (Pubitemid 41207826)
31. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37(5):634-643 (Pubitemid 37100802)
32. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients: the National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J. 2000;19(4):319-324
33. Almirante B, Rodriguez D, Cuenca-Estrella M, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44(5):1681-1685 (Pubitemid 43726255)
34. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis. 1995;20(3):571-575
35. Faix RG. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J. 1992;11(2):88-93
36. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998;26(5):1086-1088 (Pubitemid 28215469)
37. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20(12):1119-1124 (Pubitemid 34016422)
38. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29(2):253-258 (Pubitemid 29380179)
39. Bonassoli LA, Bertoli M, Svidzinski TI. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect. 2005;59(2):159-162 (Pubitemid 40058043)
40. van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia. 2007;164(6):287-293 (Pubitemid 47622127)
41. Walsh TJ, Adamson PC, Seibel NL, et al. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005;49(11):4536-4545 (Pubitemid 41552583)
42. Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother. 2004;48(6):2166-2172 (Pubitemid 38691615)